Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Should see 0.70++ closing today
$STAB
Read $STAB CORPORATE DECK PRESENTATION here >>
https://ir.staterabiopharma.com/static-files/3a2db473-b53f-461c-b836-69f2c17735e1
$STAB will continue to move upward before EoD
$STAB sitting on the launching pad to take off. Bullish will created from this level.
Friday Afternoon push coming
Nice .. Agreed
Up over 5% so far today on light volume. Once news hits and the volume comes the top will POP off of this one.. She has a super light float. $$$
$STAB
Bright future for $STAB >> This is a $471.02 billion massive market by 2027, according to stocknews.com. It’s growing at a CAGR of 9.1+%.
Up over 5% so far today on light volume. Once news hits and the volume comes the top will POP off of this one.. She has a super light float. $$$
$STAB
That's what I'm hoping for. Would be a great way to end the week..
"0.70 is showing up in the trading list. We might get at the EOD"
Looks like sellers are gone
L2 looking super thin all the way up!!
Bid sitters need to start slapping that ask
BID sitters just trying to get a fill. Put on ignore. Everyone here knows the DD is solid.
$STAB
$STAB as a Biopharmaceutical stocks have profitable catalysts in 2022
YUP. $STAB is a clinical stage biopharmaceutical company. It targets autoimmune neutropenia/anemia emerging viruses. These include clinical programs for Crohn’s disease and pancreatic cancer.
Agree. This biopharmaceutical company performing clinical stage research are RISING IN VALUATION
STAB should be on our #nasdaq #pennystocks Watch List as THEY ARE NOW progressing with next-gen R&D on its proprietary platform.
STAB should be on our #nasdaq #pennystocks Watch List as THEY ARE NOW progressing with next-gen R&D on its proprietary platform.
UP we go $STAB
0.70 is showing up in the trading list. We might get at the EOD
Me too. All we need is keep on holding the strong position and a little bit of patience
I'm holding tight for multi dollars
$STAB
0.70 is showing up in the trading list. We might get at the EOD
I'm holding tight for multi dollars
$STAB
Impatient folks will kick their own butts soon for selling too cheap...
Lets take out the 67's on the ASK and get her rolling past 70 today!! $$$
This sector of stocks clinically tests the performance of commercially-potential candidate drugs.
Why $STAB Matters To Investors. Here are some key indicators for buying into STAB stocks in 2022:
* STAB has massive market opportunity. A $471.02 billion by 2027, according to stocknews.com. It’s growing at a CAGR of 9.1+%.
* The COVID-19 pandemic has settled into an endemic. Drug candidates remain profit makers but they focus now on non-hospitalized patients.
* Worldwide countries need to catch up with primary pandemic drugs from biopharmaceutical companies that pass clinical tests and are commercialized.
* Offshoot strains remain as variants globally. Ongoing vaccines are needed in low income countries to maintain reduced infection rates.
* Ongoing research trials continue for cancers, inflammatory pain and other rare diseases as the pandemic transitions into an endemic.
Great post JennyT
Pandemic Transitions Into Lucrative Endemic For Biopharmaceuticals is the BIG opportunity for $STAB
Why $STAB Matters To Investors. Here are some key indicators for buying into STAB stocks in 2022:
* STAB has massive market opportunity. A $471.02 billion by 2027, according to stocknews.com. It’s growing at a CAGR of 9.1+%.
* The COVID-19 pandemic has settled into an endemic. Drug candidates remain profit makers but they focus now on non-hospitalized patients.
* Worldwide countries need to catch up with primary pandemic drugs from biopharmaceutical companies that pass clinical tests and are commercialized.
* Offshoot strains remain as variants globally. Ongoing vaccines are needed in low income countries to maintain reduced infection rates.
* Ongoing research trials continue for cancers, inflammatory pain and other rare diseases as the pandemic transitions into an endemic.
$STAB is a rising Rockstar in the Biopharma Global Space.
She looks like she is about to POP!
Management is top notch. A real good team..
$STAB
Yep. Those who sold have absolutely no idea how big this will be >>> Statera Research is based on the discovery that STAT-200, which originally was designed to antagonize opioid receptors, modulates multiple signaling pathways through receptors known as TLRs.
These receptors act as master controllers of inflammation. Statera’s discovery platform identifies novel compositions that build upon STAT-200 by modulating multiple cellular targets, versus one, to restore cellular homeostasis.
These findings have led to the selection of promising new compositions with the potential to treat a range of inflammatory-related diseases.
$STAB
BID sitters just trying to get a fill. Put on ignore. Everyone here knows the DD is solid.
$STAB
Agreed. Nice hit 28,962 shares at 0.65 at the ask. Going up.
Big things in the works
$STAB
$STAB President and CEO, Michael K. Handley, says company's clinical stage pipeline has the Company well positioned to achieve numerous milestones in 2022.
CATALYST:
$STAB is advancing next-gen research activities based on proprietary compositions from its own STAT-200 platform. The result is that promising new compositions are being developed to treat a range of inflammatory diseases.
Very Possible ddog .7 Break and Hold
Could see a 70 break here today. STAB looking strong even before the news hits.
$STAB
3 areas of Importance.. You have not responded about these
1.) Crohn's Trial
2.) Covid19 Vaccine
3.) Inflammation trials
Then Whay are you here?
She is building a solid base at these levels before the 70 break
Could see a 70 break here today. STAB looking strong even before the news hits.
$STAB
No worries bro she is going higher. Hold'em tight! $$$
Bid/Ask
0.6501 / 0.66
B/A Size
100 X 5,000
Volume
427,200
$STAB
Quite a change in mindset here - from rocket launch, multiple dollars, redefining the biopharma landscape to patiently waiting for 64 cents. Perhaps the reality of stab financials and last offering is sinking in.
Patiently waiting here
A little more pressure on the ask and we could go up.
Careful what you wish for. Losing $34 million last year and running out of cash, the next news might be about another stock offering. And as it stands right now, the offering would probably be priced much lower than the last one. Not a good formula.
In the red again in spite of all the effort.
Good morning WHIP THE HORSE.. Should see a nice Friday here.
$STAB
Followers
|
78
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3504
|
Created
|
05/13/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |